Freeport-McMoRan beats quarterly profit estimates-March 2024-www.financetom.com

Freeport-McMoRan beats quarterly profit estimates

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Freeport-McMoRan beats quarterly profit estimates

Apr 23, 2024 5:30 AM

April 23 (Reuters) - Copper miner Freeport-McMoRan ( FCX )

beat Wall Street estimates for first-quarter profit on

Tuesday, helped by higher production.

On an adjusted basis, the Phoenix, Arizona-based company

earned 32 cents per share for the three months ended March 31,

compared with the average analyst estimate of 26 cents per

share, according to LSEG data.

(Reporting by Sourasis Bose in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： BRIEF-Crescita To Acquire Strategic Assets Of Occy Laboratory Next page： Castlelake to buy up to $1.2 bln in consumer loans from Upstart

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Crescita To Acquire Strategic Assets Of Occy Laboratory

Jun 20, 2024

June 20 (Reuters) - Crescita Therapeutics Inc ( CRRTF ): * CRESCITA TO ACQUIRE STRATEGIC ASSETS OF OCCY LABORATORY Source text for Eikon: Further company coverage: ...

Castlelake to buy up to $1.2 bln in consumer loans from Upstart

Jun 20, 2024

June 20 (Reuters) - Private credit lender Castlelake will buy up to $1.2 billion in consumer installment loans from fintech firm Upstart to expand its foothold in the retail lending space, it said on Thursday. The deal underscores how investment firms are increasingly pushing into businesses that have traditionally been dominated by banks as high interest rates and the fear...

BRIEF-Greenridge Exploration Announces Acquisition Of Ontario Uranium Projects

Jun 20, 2024

June 20 (Reuters) - Greenridge Exploration Inc: * GREENRIDGE EXPLORATION ANNOUNCES ACQUISITION OF ONTARIO URANIUM PROJECTS Source text for Eikon: Further company coverage: ...

Crescita Therapeutics Agrees to Buy Strategic Assets of Occy Laboratory

Jun 20, 2024

08:29 AM EDT, 06/20/2024 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) , which operates in the commercial dermatology market, said on Thursday that it has agreed to buy all of the non-real estate business assets of Occy Laboratory, a Laval-based manufacturer and distributor of high-quality dermo-cosmetic products. The acquired assets include Occy's manufacturing equipment, inventory, customer network, and intellectual...